Fmoc-His-Aib-OH is a protected dipeptide building block used in solid-phase peptide synthesis. It consists of an N-terminal Fmoc-protected histidine linked to an alpha-methylalanine (Aib) residue, which introduces conformational constraints into peptide sequences.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1446013-07-5
Trans-N-boc-4-hydroxy-D-proline
pharmaceutical intermediate
Boc-L-Glutamic acid
pharmaceutical intermediate
N-Fmoc-N'-Cbz-L-2,4-diaminobutyric acid
pharmaceutical intermediate
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanine
pharmaceutical intermediate
2-(1-(1-Methylethyl)-1H-pyrazol-5-yl)-3-pyridinemethanol
pharmaceutical intermediate
3-(chloromethyl)-2-(1-isopropyl-1H-pyrazol-5-yl)pyridine hydrochloride
pharmaceutical intermediate
6-(6-(Trifluoromethyl)pyridin-2-yl)-1,3,5-triazine-2,4(1H,3H)-dione
pharmaceutical intermediate
1-N-Boc-2-pyrrolidinonitrile
pharmaceutical intermediate
2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-2-methylpropanoic acid
DRXNKOXLDLFGEG-NRFANRHFSA-N
CC(C)(C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24